Peristeen Bowel Irrigation System in Cauda Equina

The Use of the Peristeen Bowel Irrigation System for People With Cauda Equina Syndrome

To compare the Peristeen Anal Irrigation System with conservative bowel management in a prospective study among spinal cord injured patients with lower motor neuron neurogenic bowel dysfunction.

Study Overview

• Status: Completed
• Conditions: Cauda Equina Syndrome
• Intervention / Treatment: Device: Peristeen Bowel Irrigation System

Detailed Description

People with spinal cord injury (SCI) often have severe problems with management of bowel function, including incontinence, impaction, lengthy bowel routines and extremely slow transit times.The anal irrigation system is a recently available system to help patients with bowel dysfunction empty their bowels by using pulse water irrigation. The system consists of a rectal balloon catheter, manual pump and water container.

• Study Type: Interventional
• Enrollment (Actual): 12
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Manitoba
    • Winnipeg, Manitoba, Canada, R3A 1M4
      • WRHA Health Sciences Centre Rehabilitation Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Male or female >18 years or older
• Cauda equina spinal injury at least 12 months previously, with lower motor neuron bowel dysfunction and at least one of the following symptoms:
• Spending 30 minutes or more attempting to defecate each day or every second day
• Episodes of fecal incontinence once or more per month
• Abdominal discomfort before or during defecation

Exclusion Criteria:

• Coexisting major unresolved physical problems due to the injury
• Performance of transanal irrigation on a regular basis
• Evidence of bowel obstruction or active inflammatory bowel disease
• History of cerebral palsy, stroke, multiple sclerosis or diabetic polyneuropathy
• Previous colorectal or perineal surgery(excluding minor surgery such as hemorrhoidectomy)
• Pregnancy or lactation
• Immunosuppression
• Prior implant for sacral nerve stimulation

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Use of a bowel irrigation system; Open label. No placebo use in this study. All volunteers will trial the bowel irrigation system. Eligible volunteers will be those patients who have failed conventional supportive bowel care.	Device: Peristeen Bowel Irrigation System; A complete system for bowel Irrigation to manage bowel dysfunction

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline on Cleveland Clinic Constipation Scoring System after 10 weeks of treatment	A scoring system with a range of 0-30, with 30 representing the most severe symptoms. Will be used for volunteers whose primary complaint at baseline is constipation.	At baseline Visit and again after 10 weeks of treatment
Change from baseline on the St. Mark's Fecal Incontinence Grading System after 10 weeks of treatment.	A Grading system with a range of 0-24, with 24 representing the most severe symptoms. This will be used for volunteers whose primary complaint at baseline is fecal incontinence.	At baseline and again after 10 weeks of treatment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline in The Neurogenic Bowel Dysfunction Score after 10 weeks of treatment	A symptom score ranging from 0-47, where each symptom of neurogenic bowel is weighted concerning it's impact on quality of life. A score of 47 represents severe symptoms.	At baseline and again after 10 weeks of treatment
Change from baseline in a modified American Society of Colon and Rectal Surgeons fecal incontinence score after 10 weeks of treatment.	Symptom-related Quality of Life Score	At baseline and again after 10 weeks of treatment
Change from baseline measurement of Colonic Transit Time (CTT)after 10 weeks of treatment	The Metcalf method will be used.At the screening visit,eligible volunteers will be given a 7-day bowel diary and 3 SitzMark capsules with instructions on how to complete the diary and when to take the capsules. Abdominal X-rays will be obtained on Day 4 and 7. The patient will repeat the diary, SitzMark capsules and X-rays during the last week of study treatment.	At baseline and again after 10 weeks of treatment.
Change from baseline on a numeric box scale to measure bowel function, influence on daily activities, and general satisfaction after 10 weeks of treatment.	Numeric box scales with a range of 1-10	At baseline and after 10 weeks of treatment.
Measurement of Influence of Current Bowel Management on Quality of Life	A numeric box scale with a range of 0-10, with 0 representing great reduction and 10 representing great improvement.	After 10 weeks of treatment

Collaborators and Investigators

• Sponsor: University of Manitoba
• Collaborators: Manitoba Spinal Cord Injury Research Committee; Canadian Paraplegic Association

Study record dates

Study Major Dates

• Study Start: March 1, 2013
• Primary Completion (Actual): April 1, 2016
• Study Completion (Actual): July 1, 2016

Study Registration Dates

• First Submitted: January 30, 2013
• First Submitted That Met QC Criteria: February 1, 2013
• First Posted (Estimate): February 5, 2013

Study Record Updates

• Last Update Posted (Estimate): July 6, 2016
• Last Update Submitted That Met QC Criteria: July 4, 2016
• Last Verified: July 1, 2016

More Information

Terms related to this study

• Keywords: Peristeen Bowel Irrigation System; Cauda Equina Syndrome; Lower Motor Neuron Neurogenic Bowel
• Additional Relevant MeSH Terms: Pathologic Processes; Nervous System Diseases; Infections; Disease; Neuromuscular Diseases; Peripheral Nervous System Diseases; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Nerve Compression Syndromes; Polyradiculoneuropathy; Polyneuropathies; Burkholderia Infections; Syndrome; Cauda Equina Syndrome; Glanders
• Other Study ID Numbers: 2013 (Other Grant/Funding Number: Food Innovation Center)